“[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]” (2025) Farmeconomia. Health Economics and Therapeutic Pathways, 26(1). doi:10.7175/fe.v26i1.1581.